CA1001629A - Procede de preparation de nouveaux esters de l'acide 2-alcoylthiazol 5-carboxylique - Google Patents

Procede de preparation de nouveaux esters de l'acide 2-alcoylthiazol 5-carboxylique

Info

Publication number
CA1001629A
CA1001629A CA144,628A CA144628A CA1001629A CA 1001629 A CA1001629 A CA 1001629A CA 144628 A CA144628 A CA 144628A CA 1001629 A CA1001629 A CA 1001629A
Authority
CA
Canada
Prior art keywords
alcoylthiazozol
making new
new esters
carboxilic acid
carboxilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA144,628A
Other languages
English (en)
French (fr)
Other versions
CA144628S (en
Inventor
Francois Clemence
Odile Le Martret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA1001629A publication Critical patent/CA1001629A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA144,628A 1971-06-14 1972-06-13 Procede de preparation de nouveaux esters de l'acide 2-alcoylthiazol 5-carboxylique Expired CA1001629A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7121466A FR2141526B1 (xx) 1971-06-14 1971-06-14
FR7306847A FR2247243B2 (xx) 1971-06-14 1973-02-27

Publications (1)

Publication Number Publication Date
CA1001629A true CA1001629A (fr) 1976-12-14

Family

ID=26216449

Family Applications (1)

Application Number Title Priority Date Filing Date
CA144,628A Expired CA1001629A (fr) 1971-06-14 1972-06-13 Procede de preparation de nouveaux esters de l'acide 2-alcoylthiazol 5-carboxylique

Country Status (10)

Country Link
US (1) US3853875A (xx)
JP (1) JPS5519251A (xx)
AT (1) AT317895B (xx)
BE (1) BE784777A (xx)
CA (1) CA1001629A (xx)
CH (1) CH555362A (xx)
FR (2) FR2141526B1 (xx)
GB (1) GB1382887A (xx)
NL (2) NL176072C (xx)
SE (1) SE389673B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411900A (en) * 1980-01-03 1983-10-25 Fujisawa Pharmaceutical Co., Ltd. Benzhydrylpiperozinyl thiazole derivatives and pharmaceutical composition comprising the same
DE3002989A1 (de) * 1980-01-29 1981-07-30 Hoechst Ag, 6000 Frankfurt Hydroxyphenyl-thiazol, -thiazolin und -thiazolidin-carbonsaeuren, verfahren zu ihrer herstellung und ihre verwendung zur beeinflussung des kollagenstoffwechsels
DE4339617C2 (de) * 1993-11-20 2003-06-05 Vortex Gmbh Dt Rückschlagventil für ein Brauchwasser-Zirkulationssystem
US6083966A (en) 1998-08-31 2000-07-04 University Of Florida Thiazoline acid derivatives
EP1143951A3 (en) 1998-09-21 2002-02-06 University Of Florida Research Foundation, Inc. Antimalarial agents
WO2005034949A1 (en) 2003-09-09 2005-04-21 University Of Florida Desferrithiocin derivatives and their use as iron chelators
ES2614086T3 (es) 2005-04-04 2017-05-29 University Of Florida Research Foundation, Inc. Análogos de poliéter de desferritiocina
AU2008229472B2 (en) 2007-03-15 2013-03-14 University Of Florida Research Foundation, Inc. Desferrithiocin polyether analogues
CN113398126A (zh) 2011-12-16 2021-09-17 佛罗里达大学研究基金会 4′-去铁硫素类似物的用途
EP3071201A4 (en) 2013-11-22 2017-04-26 University of Florida Research Foundation, Inc. Desferrithiocin analogs and uses thereof
CN107708693A (zh) 2015-04-27 2018-02-16 佛罗里达大学研究基金会 代谢程序化的金属螯合剂及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3238203A (en) * 1962-10-12 1966-03-01 Olin Mathieson Basic esters of n-alkenoylanthranilic acid
FR2073284B1 (xx) * 1969-12-23 1973-07-13 Ferlux

Also Published As

Publication number Publication date
NL7208138A (xx) 1972-12-18
FR2247243A2 (xx) 1975-05-09
SE389673B (sv) 1976-11-15
FR2141526B1 (xx) 1975-05-30
JPS5519251A (en) 1980-02-09
NL176072C (nl) 1985-02-18
AT317895B (de) 1974-09-25
FR2247243B2 (xx) 1976-12-03
DE2228805A1 (de) 1972-12-21
US3853875A (en) 1974-12-10
GB1382887A (en) 1975-02-05
FR2141526A1 (xx) 1973-01-26
CH555362A (fr) 1974-10-31
BE784777A (fr) 1972-12-13
NL176072B (nl) 1984-09-17
DE2228805B2 (de) 1977-03-31
NL7908300A (nl) 1980-03-31

Similar Documents

Publication Publication Date Title
CA999303A (en) Process for the manufacture of acrylic acid esters
CA1001629A (fr) Procede de preparation de nouveaux esters de l'acide 2-alcoylthiazol 5-carboxylique
CA1032545A (en) Process for the manufacture of substituted o-cyanobenzoic acid esters
CA980794A (en) Process for the production of (+)-cis-, (+)-trans-mixed chrysanthemic acid
CA969742A (en) Apparatus for the production of phosphoric acid
PH9811A (en) Process for 7-beta-amino-7-alpha-methoxycephalosporanic acid esters
CA963912A (en) Process for the manufacture of dialkyl-phosphinic acid esters
YU36971B (en) Process for obtaining 7-acylamido-3-halo-3-cephem-4-carboxylic acid esters
CA1030970A (en) 5-phenylsulfinyl-2-benzimidazolyl-carbamic acid esters and process for their manufacture
CA975795A (en) Process for the production of trans-chrysanthemic acid
CA921046A (en) Process for the production of acetone-dicarboxylic acid esters
CA942766A (en) Process for the manufacture of 2-chloroethane-phosphonic acid
CA888749A (en) Process for preparing glycol type carboxylic acid esters
AU463474B2 (en) Process for producing penicillin esters
AU4231672A (en) Imidazolinyl-ethyl-dithiocarbamic acid esters and process for their manufacture
CA980793A (en) Process for the production of propionic acid
CA939369A (en) Process for preparing hydrocarbon acid esters
CA875580A (en) Process for preparing esters of p-biphenylylacetic acid
CA884292A (en) Process for producing 2-thiouridylic acid
CA866848A (en) Process for producing esters
CA879135A (en) Process for the production of acrylic acid esters
CA834230A (en) Process for the production of cyclohexenepolycarboxylic acid esters
CA871757A (en) Process for the production of acrylic acid
CA902633A (en) Process for producing cyanacrylic acid esters
CA875581A (en) Process for preparing esters of the paradiphenyl acetic acid